Monitor the Nasdaq hearing outcome in the coming weeks. If delisting occurs, expect a sharp price decline and reduced trading volume. Any reverse stock split or capital raise plan to regain compliance could cause further dilution.
Price Chart
Executive Summary
Glucotrack received two Nasdaq deficiency notices: one for failing the $1.00 minimum bid price rule and a second for failing the $2.5 million minimum stockholders' equity requirement. The company faces imminent delisting risk, with a hearing requested to appeal but no guarantee of success. The $1M market cap micro-cap is now fighting to stay listed on Nasdaq.
Key Facts
- Nasdaq staff determined to delist GCTK for non-compliance with the $1.00 minimum bid price rule (Rule 5550(a)(2)).
- A second deficiency was identified on May 15, 2026: stockholders' equity below the $2.5 million minimum (Rule 5550(b)(1)).
- Company requested a hearing by May 18, 2026, which stays delisting through the hearing process.
- No assurance of regaining compliance or continued listing; potential transfer to OTC markets.
Financial Impact
Potential loss of Nasdaq listing, which typically results in severe liquidity reduction and significant share price decline for micro-cap stocks.
Risk Factors
- Delisting from Nasdaq, forcing trading to OTC markets with lower liquidity and visibility.
- Potential reverse stock split or dilutive equity offering to meet minimum bid price or equity requirements.
- Inability to raise capital due to distressed financial condition and low market cap.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-023889 |
| Document: 0001493152-26-023889-index-headers.html | 0001493152-26-023889 |
| Document: 0001493152-26-023889-index.html | 0001493152-26-023889 |
| Document: 0001493152-26-023889.txt | 0001493152-26-023889 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 3d ago | 8-K | $0.6081 | awaiting T+60 | — | — |
Oct 19, 2026 7d ago | 8-K | $0.6511 | awaiting T+60 | — | — |
Oct 13, 2026 12d ago | S-1/A | $0.8873 | awaiting T+60 | — | — |
Oct 13, 2026 13d ago | 425 | $0.8873 | awaiting T+60 | — | — |
Sep 28, 2026 27d ago | 8-K | $1.74 | awaiting T+60 | — | — |
Sep 24, 2026 4w ago | 424B5 | $1.82 | awaiting T+60 | — | — |
Sep 24, 2026 4w ago | 8-K | $1.82 | awaiting T+60 | — | — |
Sep 23, 2026 4w ago | 425 | $2.03 | awaiting T+60 | — | — |
Sep 23, 2026 4w ago | 8-K | $2.03 | awaiting T+60 | — | — |
Sep 18, 2026 5w ago | 8-K | $2.30 | awaiting T+60 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers